NEW YORK (GenomeWeb News) – Kapa Biosystems said today that several biotech companies and research centers are using its Kapa2G Fast HotStart DNA Polymerase platform for genomic resequencing and SNP detection studies.

The company said the Kapa2G has been adopted by Agencourt Bioscience, Ceres, Memorial Sloan Kettering Cancer Center, and the National Institutes of Health's Intramural Sequencing Center.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.